Richard Shea
Direttore/Membro del Consiglio presso SYNLOGIC, INC.
Patrimonio netto: 930 $ in data 30/04/2024
Relazioni attive
| Nome | Sesso | Età | Società collegate | Collaborazione |
|---|---|---|---|---|
| Aoife Brennan | M | 48 |
Synlogic Operating Co., Inc.
 Synlogic Operating Co., Inc. Pharmaceuticals: MajorHealth Technology Synlogic Operating Co., Inc. operates as a biopharmaceutical company. The firm's pipeline focuses on rare diseases, the company is leveraging the broad potential of its synthetic biotics platform for novel drug development in major disease areas through partnerships with pharmaceutical and biotechnology companies. It also engages in development of synthetic biotics-based treatment for inflammatory bowel disease. The company was founded by James J. Collins and Timothy K. Lu in 2014 and is headquartered in Cambridge, MA. | 8 anni |
| Michael Metzger | M | 53 | 9 anni | |
| Nick Leschly | M | 51 |
Synlogic Operating Co., Inc.
Synlogic Operating Co., Inc. Pharmaceuticals: MajorHealth Technology Synlogic Operating Co., Inc. operates as a biopharmaceutical company. The firm's pipeline focuses on rare diseases, the company is leveraging the broad potential of its synthetic biotics platform for novel drug development in major disease areas through partnerships with pharmaceutical and biotechnology companies. It also engages in development of synthetic biotics-based treatment for inflammatory bowel disease. The company was founded by James J. Collins and Timothy K. Lu in 2014 and is headquartered in Cambridge, MA. | 8 anni |
| Peter Barrett | M | 71 |
Synlogic Operating Co., Inc.
Synlogic Operating Co., Inc. Pharmaceuticals: MajorHealth Technology Synlogic Operating Co., Inc. operates as a biopharmaceutical company. The firm's pipeline focuses on rare diseases, the company is leveraging the broad potential of its synthetic biotics platform for novel drug development in major disease areas through partnerships with pharmaceutical and biotechnology companies. It also engages in development of synthetic biotics-based treatment for inflammatory bowel disease. The company was founded by James J. Collins and Timothy K. Lu in 2014 and is headquartered in Cambridge, MA. | 13 anni |
| Antoine Awad | M | 44 | 6 anni | |
| Michael Powell | M | 69 |
Synlogic Operating Co., Inc.
Synlogic Operating Co., Inc. Pharmaceuticals: MajorHealth Technology Synlogic Operating Co., Inc. operates as a biopharmaceutical company. The firm's pipeline focuses on rare diseases, the company is leveraging the broad potential of its synthetic biotics platform for novel drug development in major disease areas through partnerships with pharmaceutical and biotechnology companies. It also engages in development of synthetic biotics-based treatment for inflammatory bowel disease. The company was founded by James J. Collins and Timothy K. Lu in 2014 and is headquartered in Cambridge, MA. | 7 anni |
| Mary Dooley | F | 43 | 6 anni | |
| Chau Khuong | M | 48 |
Synlogic Operating Co., Inc.
Synlogic Operating Co., Inc. Pharmaceuticals: MajorHealth Technology Synlogic Operating Co., Inc. operates as a biopharmaceutical company. The firm's pipeline focuses on rare diseases, the company is leveraging the broad potential of its synthetic biotics platform for novel drug development in major disease areas through partnerships with pharmaceutical and biotechnology companies. It also engages in development of synthetic biotics-based treatment for inflammatory bowel disease. The company was founded by James J. Collins and Timothy K. Lu in 2014 and is headquartered in Cambridge, MA. | 6 anni |
| Ed Mathers Mathers | M | 64 |
Synlogic Operating Co., Inc.
Synlogic Operating Co., Inc. Pharmaceuticals: MajorHealth Technology Synlogic Operating Co., Inc. operates as a biopharmaceutical company. The firm's pipeline focuses on rare diseases, the company is leveraging the broad potential of its synthetic biotics platform for novel drug development in major disease areas through partnerships with pharmaceutical and biotechnology companies. It also engages in development of synthetic biotics-based treatment for inflammatory bowel disease. The company was founded by James J. Collins and Timothy K. Lu in 2014 and is headquartered in Cambridge, MA. | 12 anni |
| Pierre Legault | M | 63 | 7 anni | |
| William Meury | M | 56 | 6 anni | |
| Michael Heffernan | M | 59 | 4 anni | |
| James Collins | M | 58 |
Synlogic Operating Co., Inc.
Synlogic Operating Co., Inc. Pharmaceuticals: MajorHealth Technology Synlogic Operating Co., Inc. operates as a biopharmaceutical company. The firm's pipeline focuses on rare diseases, the company is leveraging the broad potential of its synthetic biotics platform for novel drug development in major disease areas through partnerships with pharmaceutical and biotechnology companies. It also engages in development of synthetic biotics-based treatment for inflammatory bowel disease. The company was founded by James J. Collins and Timothy K. Lu in 2014 and is headquartered in Cambridge, MA. | 10 anni |
| Timothy Lu | M | 43 |
Synlogic Operating Co., Inc.
Synlogic Operating Co., Inc. Pharmaceuticals: MajorHealth Technology Synlogic Operating Co., Inc. operates as a biopharmaceutical company. The firm's pipeline focuses on rare diseases, the company is leveraging the broad potential of its synthetic biotics platform for novel drug development in major disease areas through partnerships with pharmaceutical and biotechnology companies. It also engages in development of synthetic biotics-based treatment for inflammatory bowel disease. The company was founded by James J. Collins and Timothy K. Lu in 2014 and is headquartered in Cambridge, MA. | 10 anni |
| Jennifer Jarrett | F | 53 | 6 anni | |
| Luke Albrecht | M | 45 | 8 anni | |
| Thomas J. Adam | M | - | 7 anni | |
| Brendan St Amant | M | - | 3 anni | |
| Keith Katkin | M | 52 | 7 anni | |
| Jo-Ann Beltramello | F | - | 17 anni | |
| Molly Harper | F | 48 | 3 anni | |
| Caroline Kurtz | M | - | 8 anni | |
| Anjali Ganguli | M | 48 | 9 anni |
Grafico relazionale
Relazione in diverse aziende
Relazioni precedenti
| Nome | Sesso | Età | Società collegate | Collaborazione |
|---|---|---|---|---|
| Craig Wheeler | M | 63 | 14 anni | |
| Jose-Carlos Gutiérrez-Ramos | M | 61 | 5 anni | |
| Allan Shaw | M | 59 | 1 anni | |
| Briggs Morrison | M | 65 | 9 anni | |
| John S. Pallies | M | 60 | 9 anni | |
| Alexander Nolte | M | 52 | 6 anni | |
| Arlene Morris | F | 72 | 4 anni | |
| Jay Mohr | M | - |
Variagenics, Inc.
 Variagenics, Inc. Miscellaneous Commercial ServicesCommercial Services Variagenics, Inc. develops molecular diagnostic tests by identifying genetic markers associated with response to cancer therapies, with the goal of optimizing patient care through both biopharmaceutical collaborations and its own internal research programs | 2 anni |
| Leonard Patrick Gage | M | 81 |
Genetics Institute LLC
 Genetics Institute LLC Pharmaceuticals: MajorHealth Technology Genetics Institute LLC develops pharmaceutical products through recombinant DNA and other genetic technologies. It develops drugs to make the blood of hemophiliacs clot, as well as substances that stimulate the production of red and white blood cells and proteins that enhance bone growth. The company was founded in 1980 and is headquartered in Cambridge, MA. | 9 anni |
| Todd Shegog | M | 59 | 3 anni | |
| Bruce Downey | M | 76 | 11 anni | |
| Christoph H. Westphal | M | 56 | 5 anni | |
| Ram Sasisekharan | M | 58 | 9 anni | |
| Ben Shapiro | M | 84 | 13 anni | |
| Kim Kamdar | M | 56 | 11 anni | |
| Michael Meyers | M | 74 | 7 anni | |
| Ivor Royston | M | 79 | 4 anni | |
| Steven Gilman | M | 71 | 4 anni | |
| Young Kwon | M | 52 | 10 anni | |
| Thomas Paul Koestler | M | 71 | 9 anni | |
| Corey Fishman | M | 59 | 4 anni | |
| Luke Evnin | M | 60 | 6 anni | |
| Elizabeth Stoner | M | 73 | 13 anni | |
| Michael Burgess | M | 61 | 4 anni | |
| George W. Sledge | M | 73 | 3 anni | |
| Georges Gemayel | M | 64 | 4 anni | |
| Robert Langer | M | 75 | 8 anni | |
| Marsha Fanucci | F | 70 | 11 anni | |
| Henry Chen | M | 53 | 3 anni | |
| Bruce A. Leicher | M | 68 | 10 anni | |
| Peter Hutt | M | 89 | 13 anni | |
| Lisa Kelly-Croswell | F | 57 | 3 anni | |
| John Clarke | M | 70 | 13 anni | |
| James Sulat | M | 73 | 11 anni | |
| Scott M. Storer | M | - | 2 anni | |
| Lisa Carron Shmerling | F | 63 | - | |
| Patricia Hurter | M | 60 | 5 anni | |
| Philip Nickson | M | 45 | 9 anni | |
| Robert D. Ciappenelli | M | 57 | 2 anni | |
| Narinder Singh | M | 51 | 3 anni | |
| Michael Morneau | M | 58 | 2 anni | |
| Scott Plevy | M | - | - | |
| Jan Hillson | M | 71 | 3 anni | |
| Anthony Manning | M | 62 | - | |
| Steven Fruchtman | M | 73 | 1 anni | |
| Eric Shaff | M | 48 | 2 anni | |
| Takashi Kishimoto | M | 64 | 5 anni | |
| Matthew P. Ottmer | M | 53 | 2 anni | |
| Thomas Spitznagel | M | 57 |
Genetics Institute LLC
Genetics Institute LLC Pharmaceuticals: MajorHealth Technology Genetics Institute LLC develops pharmaceutical products through recombinant DNA and other genetic technologies. It develops drugs to make the blood of hemophiliacs clot, as well as substances that stimulate the production of red and white blood cells and proteins that enhance bone growth. The company was founded in 1980 and is headquartered in Cambridge, MA. | 4 anni |
| Daniel Rosan | M | - | 1 anni | |
| Alex Fotopoulos | M | 55 | 5 anni | |
| Adelene Perkins | F | 54 |
Genetics Institute LLC
Genetics Institute LLC Pharmaceuticals: MajorHealth Technology Genetics Institute LLC develops pharmaceutical products through recombinant DNA and other genetic technologies. It develops drugs to make the blood of hemophiliacs clot, as well as substances that stimulate the production of red and white blood cells and proteins that enhance bone growth. The company was founded in 1980 and is headquartered in Cambridge, MA. | 7 anni |
| Gary Hattersley | M | 57 |
Genetics Institute LLC
Genetics Institute LLC Pharmaceuticals: MajorHealth Technology Genetics Institute LLC develops pharmaceutical products through recombinant DNA and other genetic technologies. It develops drugs to make the blood of hemophiliacs clot, as well as substances that stimulate the production of red and white blood cells and proteins that enhance bone growth. The company was founded in 1980 and is headquartered in Cambridge, MA. | 8 anni |
| Dean A. Falb | M | 63 | 5 anni | |
| Zoltan A. Csimma | M | 82 |
Genetics Institute LLC
Genetics Institute LLC Pharmaceuticals: MajorHealth Technology Genetics Institute LLC develops pharmaceutical products through recombinant DNA and other genetic technologies. It develops drugs to make the blood of hemophiliacs clot, as well as substances that stimulate the production of red and white blood cells and proteins that enhance bone growth. The company was founded in 1980 and is headquartered in Cambridge, MA. | 10 anni |
| Garen Bohlin | M | 76 |
Genetics Institute LLC
Genetics Institute LLC Pharmaceuticals: MajorHealth Technology Genetics Institute LLC develops pharmaceutical products through recombinant DNA and other genetic technologies. It develops drugs to make the blood of hemophiliacs clot, as well as substances that stimulate the production of red and white blood cells and proteins that enhance bone growth. The company was founded in 1980 and is headquartered in Cambridge, MA. | 14 anni |
| Karen Dawes | F | 72 |
Genetics Institute LLC
Genetics Institute LLC Pharmaceuticals: MajorHealth Technology Genetics Institute LLC develops pharmaceutical products through recombinant DNA and other genetic technologies. It develops drugs to make the blood of hemophiliacs clot, as well as substances that stimulate the production of red and white blood cells and proteins that enhance bone growth. The company was founded in 1980 and is headquartered in Cambridge, MA. | 4 anni |
| Steven B. Brugger | M | 65 | 8 anni | |
| John Bishop | M | 62 | 12 anni | |
| Elizabeth A. Olek | M | 59 |
Genetics Institute LLC
Genetics Institute LLC Pharmaceuticals: MajorHealth Technology Genetics Institute LLC develops pharmaceutical products through recombinant DNA and other genetic technologies. It develops drugs to make the blood of hemophiliacs clot, as well as substances that stimulate the production of red and white blood cells and proteins that enhance bone growth. The company was founded in 1980 and is headquartered in Cambridge, MA. | 4 anni |
| Ramani Varanasi | F | 54 | - | |
| John L. Zabriskie | M | 85 | - | |
| Gabriel Schmergel | M | 83 |
Genetics Institute LLC
Genetics Institute LLC Pharmaceuticals: MajorHealth Technology Genetics Institute LLC develops pharmaceutical products through recombinant DNA and other genetic technologies. It develops drugs to make the blood of hemophiliacs clot, as well as substances that stimulate the production of red and white blood cells and proteins that enhance bone growth. The company was founded in 1980 and is headquartered in Cambridge, MA. | 15 anni |
| Paul S. Miller | M | 65 | - | |
| Jeffrey S. Stubbs | M | 61 | - | |
| Michael F. Jarvis | M | - |
Genetics Institute LLC
Genetics Institute LLC Pharmaceuticals: MajorHealth Technology Genetics Institute LLC develops pharmaceutical products through recombinant DNA and other genetic technologies. It develops drugs to make the blood of hemophiliacs clot, as well as substances that stimulate the production of red and white blood cells and proteins that enhance bone growth. The company was founded in 1980 and is headquartered in Cambridge, MA. | 8 anni |
| Robert H. Tidwell | M | 80 |
Genetics Institute LLC
Genetics Institute LLC Pharmaceuticals: MajorHealth Technology Genetics Institute LLC develops pharmaceutical products through recombinant DNA and other genetic technologies. It develops drugs to make the blood of hemophiliacs clot, as well as substances that stimulate the production of red and white blood cells and proteins that enhance bone growth. The company was founded in 1980 and is headquartered in Cambridge, MA. | 5 anni |
| Gregg Beloff | M | 56 | 3 anni | |
| Catharine E. Johnson | M | - | - | |
| Stephen T. Reeders | M | 70 | 5 anni | |
| Stephen Albert Martin | M | 54 |
Genetics Institute LLC
Genetics Institute LLC Pharmaceuticals: MajorHealth Technology Genetics Institute LLC develops pharmaceutical products through recombinant DNA and other genetic technologies. It develops drugs to make the blood of hemophiliacs clot, as well as substances that stimulate the production of red and white blood cells and proteins that enhance bone growth. The company was founded in 1980 and is headquartered in Cambridge, MA. | 5 anni |
| John W. Loewy | M | - |
Genetics Institute LLC
Genetics Institute LLC Pharmaceuticals: MajorHealth Technology Genetics Institute LLC develops pharmaceutical products through recombinant DNA and other genetic technologies. It develops drugs to make the blood of hemophiliacs clot, as well as substances that stimulate the production of red and white blood cells and proteins that enhance bone growth. The company was founded in 1980 and is headquartered in Cambridge, MA. | 5 anni |
| John L. Knopf | M | 71 |
Genetics Institute LLC
Genetics Institute LLC Pharmaceuticals: MajorHealth Technology Genetics Institute LLC develops pharmaceutical products through recombinant DNA and other genetic technologies. It develops drugs to make the blood of hemophiliacs clot, as well as substances that stimulate the production of red and white blood cells and proteins that enhance bone growth. The company was founded in 1980 and is headquartered in Cambridge, MA. | 16 anni |
| Daphne Karydas | F | 49 | 1 anni | |
| Paul David Goldenheim | M | - | - | |
| James M. Roach | M | 64 | 8 anni | |
| Jun Lu | M | 58 | 2 anni |
Statistiche
| Paese | Relazioni | % del totale |
|---|---|---|
| Stati Uniti | 100 | 100.00% |
Età delle relazioni
Attive
Scorse
Uomo
Donna
Amministratori
Dirigenti
Provenienza delle relazioni
- Borsa valori
- Insiders
- Richard Shea
- Contatti personali
